Identification of prognostic biomarkers in papillary renal cell carcinoma and PTTG1 may serve as a biomarker for predicting immunotherapy response

References

• Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. Clinicians. 2010;51(1):15–36.
   Google Scholar
• Kuroda N, Toi M, Hiroi M, et al. Review of papillary renal cell carcinoma with focus on clinical and pathobiological aspects. J Histol Histopathol. 2003;18(2):487–494.
   Google Scholar
• Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol. 1997;10(6):537–544.
   PubMed Web of Science ®Google Scholar
• Akhtar MA., Al-Bozom IA, Hussain TAl. Papillary renal cell carcinoma (PRCC): an update. Adv Anat Pathol. 2019;26(2):124–132.
   PubMed Web of Science ®Google Scholar
• Medeiros LJ, Gelb AB, Weiss LM. Renal cell carcinoma. Prognostic significance of morphologic parameters in 121 cases. J Cancer. 1988;61(8):1639–1651.
   Google Scholar
• Delahunt B, Eble JN, McCredie MR, et al. Morphologic typing of papillary renal cell carcinoma: comparison of growth kinetics and patient survival in 66 cases. Hum Pathol. 2001;32(6):590–595.
   PubMed Web of Science ®Google Scholar
• Schmidt L, Nickerson M, Angeloni D, et al. Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene. J Urol. 2004;172(4 Pt 1):1256–1261.
   PubMed Web of Science ®Google Scholar
• Sourbier C, Liao P-J, Ricketts C, et al. Targeting loss of the hippo signaling pathway in NF2-deficient papillary kidney cancers. Oncotarget. 2018;9(12):10723–10733.
   PubMedGoogle Scholar
• Kovac M, Navas C, Horswell S, et al. Recurrent chromosomal gains and heterogeneous driver mutations characterise papillary renal cancer evolution. Nat Commun. 2015;6:6336.
   PubMed Web of Science ®Google Scholar
• Fay AP, Sabina S, Choueiri TK. MET as a target in papillary renal cell carcinoma. Clin Cancer Res. 2014;20(13):3361–3363.
   PubMed Web of Science ®Google Scholar
• Durinck S, Stawiski EW, Pavía-Jiménez A, et al. Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes. Nat Genet. 2015;47(1):13–21.
   PubMed Web of Science ®Google Scholar
• Sánchez-Gastaldo A, Kempf E, González Del Alba A, et al. Systemic treatment of renal cell cancer: a comprehensive review. Cancer Treat Rev. 2017;60:77–89.
   PubMed Web of Science ®Google Scholar
• Edgar R, Domrachev M, Lash AE. Gene expression omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002;30(1):207–210.
   PubMed Web of Science ®Google Scholar
• Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The gene ontology consortium. Nat Genet. 2000;25(1):25–29.
   PubMed Web of Science ®Google Scholar
• Kanehisa M. The KEGG database. Novartis Found Symp. 2002;247:91–101.
   Google Scholar
• Franceschini A, Franceschini A, Szklarczynk D, Frankild S, et al. STRING v9.1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res. 2013;41(Database issue):D808–15.
   PubMed Web of Science ®Google Scholar
• Smoot ME, Ono K, Ruscheinski J, et al. Cytoscape 2.8: new features for data integration and network visualization. Bioinformatics. 2011;27(3):431–432.
   PubMed Web of Science ®Google Scholar
• Bandettini WP, Kellman P, Mancini C, et al. Multicontrast delayed enhancement (MCODE) improves detection of subendocardial myocardial infarction by late gadolinium enhancement cardiovascular magnetic resonance: a clinical validation study. J Cardiovasc Magn Reson. 2012;14(1):83.
   PubMed Web of Science ®Google Scholar
• Yu G, Wang L-G, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287.
   PubMed Web of Science ®Google Scholar
• Camp RL, Dolled-Filhart M, Rimm DL. X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization. Clin Cancer Res. 2004;10(21):7252–7259.
   PubMed Web of Science ®Google Scholar
• Li T, Fan J, Wang B, et al. TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. 2017;77(21):e108–e110.
   PubMed Web of Science ®Google Scholar
• Ru B, Wong CN, Tong Y, et al. TISIDB: an integrated repository portal for tumor-immune system interactions. Bioinformatics. 2019;35(20):4200–4202.
   PubMed Web of Science ®Google Scholar
• Sun D, Wang J, Han Y, et al. TISCH: a comprehensive web resource enabling interactive single-cell transcriptome visualization of tumor microenvironment. Nucleic Acids Res. 2021;49(D1):D1420–d1430.
   PubMed Web of Science ®Google Scholar
• Wang J, Xu WH, Wei Y, et al. Elevated MRE11 expression associated with progression and poor outcome in prostate cancer. J Cancer. 2019;10(18):4333–4340.
   PubMed Web of Science ®Google Scholar
• Mancilla-Jimenez R, Stanley RJ, Blath RA. Papillary renal cell carcinoma: a clinical, radiologic, and pathologic study of 34 cases. Cancer. 1976;38(6):2469–2480.
   PubMed Web of Science ®Google Scholar
• Myrie KA, Percy MJ, Azim JN, et al. Mutation and expression analysis of human BUB1 and BUB1B in aneuploid breast cancer cell lines. Cancer Lett. 2000;152(2):193–199.
   PubMed Web of Science ®Google Scholar
• Scintu M, Vitale R, Prencipe M, et al. Genomic instability and increased expression of BUB1B and MAD2L1 genes in ductal breast carcinoma. Cancer Letters. 2007;254(2):298–307.
   PubMed Web of Science ®Google Scholar
• Sekino Y, Han X, Kobayashi G, et al. BUB1B overexpression is an independent prognostic marker and associated with CD44, p53, and PD-L1 in renal cell carcinoma. Oncology. 2021;99(4):240–250.
   PubMed Web of Science ®Google Scholar
• Gavet O, Pines JJDC. Progressive activation of CyclinB1-Cdk1 coordinates entry to mitosis. Dev Cell. 2010;18(4):533–543.
   PubMed Web of Science ®Google Scholar
• Yuan J, Yan R, Krämer A, et al. Cyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cells. Oncogene. 2004;23(34):5843–5852.
   PubMed Web of Science ®Google Scholar
• Harada H, Omura K, Nakajima Y, et al. Cyclin B1 is useful to predict occult cervical lymph node metastases in tongue carcinoma. J Exp Clin Cancer Res. 2006;25(3):351–356.
   PubMed Web of Science ®Google Scholar
• Shubbar E, Kovács A, Hajizadeh S, et al. Elevated cyclin B2 expression in invasive breast carcinoma is associated with unfavorable clinical outcome. BMC Cancer. 2013;13:1.
   PubMed Web of Science ®Google Scholar
• Fernandez-Ranvier GG, Julie W, Ru-Fang Y, et al. Identification of biomarkers of adrenocortical carcinoma using genomewide gene expression profiling. Arch Surg. 2008;143(9):841–846.
   PubMedGoogle Scholar
• Seon-Hwa P, Gyung-Ran Y, Woo-Ho K, et al. NF-Y-dependent cyclin B2 expression in colorectal adenocarcinoma. Clin Cancer Res. 2007;13(3):858–867.
   PubMed Web of Science ®Google Scholar
• Ivana DM, Rosa V, Anne W, et al. HMGA proteins up-regulate CCNB2 gene in mouse and human pituitary adenomas. Cancer Res. 2009;69(5):1844–1850.
   PubMed Web of Science ®Google Scholar
• Mo ML, Chen Z, Li J, et al. Use of serum circulating CCNB2 in cancer surveillance. Int J Biol Markers. 2010;25(4):236–242.
   PubMed Web of Science ®Google Scholar
• Loren M, Elena DR, Gopeshwar N, et al. Complete loss of the tumor suppressor MAD2 causes premature cyclin B degradation and mitotic failure in human somatic cells. Proc Natl Acad Sci USA. 2004;101(13):4459–4464.
   PubMed Web of Science ®Google Scholar
• Liu X, Winey M. The MPS1 family of protein kinases. Annu Rev Biochem. 2012;81:561–585.
   PubMed Web of Science ®Google Scholar
• Jemaà M, Manic G, Lledo G, et al. Whole-genome duplication increases tumor cell sensitivity to MPS1 inhibition. Oncotarget. 2016;7(1):885–901.
   PubMedGoogle Scholar
• Marieke A, Spiros L, Turner NC. Tumour selective targeting of cell cycle kinases for cancer treatment. Curr Opin Pharmacol. 2013;13(4):529–535.
   PubMed Web of Science ®Google Scholar
• Chu CM. Natural history of chronic hepatitis B virus infection in adults with emphasis on the occurrence of cirrhosis and hepatocellular carcinoma. J Gastroenterol Hepatol. 2000;15 Suppl:E25–E30.
   PubMed Web of Science ®Google Scholar
• Geley S, Kramer E, Gieffers C, et al. Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin a starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint. J Cell Biol. 2001;153(1):137–148.
   PubMed Web of Science ®Google Scholar
• Ohtoshi A, Maeda T, Higashi H, et al. Human p55(CDC)/Cdc20 associates with cyclin a and is phosphorylated by the cyclin A-Cdk2 complex. Biochem Biophys Res Commun. 2000;268(2):530–534.
   PubMed Web of Science ®Google Scholar
• Amador V, Ge S, Santamaría PG, et al. APC/C(Cdc20) controls the ubiquitin-mediated degradation of p21 in prometaphase . Mol Cell. 2007;27(3):462–473.
   PubMed Web of Science ®Google Scholar
• Harley ME, Allan LA, Sanderson HS, et al. Phosphorylation of Mcl-1 by CDK1-cyclin B1 initiates its Cdc20-dependent destruction during mitotic arrest. Embo J. 2010;29(14):2407–2420.
   PubMed Web of Science ®Google Scholar
• Tye BK. MCM proteins in DNA replication. Annu Rev Biochem. 1999;68(68):649–686.
   PubMedGoogle Scholar
• Williams GH, Swinn R, Prevost AT, et al. Diagnosis of oesophageal cancer by detection of minichromosome maintenance 5 protein in gastric aspirates. Br J Cancer. 2004;91(4):714–719.
   PubMed Web of Science ®Google Scholar
• Going JJ, Keith WN, Neilson L, et al. Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in dysplastic squamous oesophageal epithelium and Barrett’s mucosa. J Gut. 2002;50(3):373–377.
   PubMed Web of Science ®Google Scholar
• Zhang X, Horwitz GA, Prezant TR, et al. Structure, expression, and function of human pituitary tumor-transforming gene (PTTG). Mol Endocrinol. 1999;13(1):156–166.
   PubMedGoogle Scholar
• Mccabe CJ, Boelaert K, Tannahill LA, et al. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors. J Clin Endocrinol Metab. 2002;87(9):4238–4244.
   PubMed Web of Science ®Google Scholar